Savings Card Terms & Conditions

Terms of Use

Subject to additional terms below, if you are an eligible patient age 18 or older, or the legal representative of a patient under age 18, with a valid ASTEPRO 0.15% prescription, you can use this card. You must deduct the value of this offer from any insurance reimbursement claim that you submit or that is submitted for you.

Eligibility & Exclusions

The card is not valid for prescriptions partly or fully reimbursable by Medicare (including Part D), Medicaid, CHAMPUS, TRICARE, DoD, VA, or other federal or state government programs (including patient assistance programs). This card is not valid for Massachusetts residents or where otherwise prohibited by law. This card is not valid for cash-paying patients or patients whose private health care or prescription plans pay the full cost of their prescriptions. This card cannot be combined with other ASTEPRO 0.15% coupons, rebates, free trials, or offers.

Limitations

Subject to all applicable federal, state, and local laws. This card is not health insurance and is not transferable. Limit 1 card per patient during the offer period. This card is serialized and may not be reproduced. We are not responsible for lost, damaged, or misdirected mail.

Offer expires December 31, 2012.

This offer is the property of Meda Pharmaceuticals Inc. and OPUS Health, which reserve the right to rescind, revoke, or amend the offer program without notice.

By using this card, you represent that you will comply with all terms and conditions of this program and your health insurance or prescription plan. We rely on that representation.

Please see full Prescribing Information available from your health care professional or at www.Astepro.com.

 

Indication

ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.

Important Risk Information

  • Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
  • Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
  • In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
  • Pregnancy Category C: Based on animal data, may cause fetal harm
    Please see full Prescribing Information
    You are encouraged to report negative side effects of prescription drugs to the FDA.
    Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088